EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JULY 10, 2018
Want to embed a link to this report in your story? Link will be live at the embargo time: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.8102
Bottom Line: For approximately 20 percent of individuals who experience a stroke due to atrial fibrillation (AF; an irregular and often rapid heart rate), the occurrence of AF was not diagnosed until the time of their stroke or shortly afterward. Improved AF diagnosis and treatment could reduce the risk of stroke. In a randomized trial that included about 2,600 participants at increased risk of AF, immediate monitoring with a home-based, self-applied wearable ECG sensor patch resulted in a higher rate of AF diagnosis after four months compared with delayed monitoring (3.9 percent vs 0.9 percent). In an observational study, monitored individuals had higher rates of AF diagnosis, greater initiation of blood thinners, but also increased health care resource use at one year compared with non-monitored controls. Further research is needed regarding the clinical implications of these findings.
Authors: Steven R. Steinhubl, M.D., Scripps Translational Science Institute, La Jolla, California, and coauthors
To Learn More: The full study is available on the For The Media website.
Related material available on the For The Media website:
A summary video is available for download or to embed on your website. Download the video as a high-quality MP4 file by clicking on this link and then right-clicking and selecting “save video as.” In addition, you may copy and paste the html code below to embed the video on your website.
The editorials: “Evaluating Health Technology Through Pragmatic Trials,” by Eric D. Peterson, M.D., M.P.H., of Duke University Medical Center, Durham, North Carolina, and Robert A. Harrington, M.D., Stanford University, Stanford, California; and “Screening for Atrial Fibrillation With a Wearable Device,” by Benjamin A. Steinberg, M.D., M.H.S., University of Utah Health Sciences Center, Salt Lake City, and Jonathan P. Piccini, M.D., M.H.S., Duke University Medical Center, Durham, North Carolina.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email email@example.com.
Video embed code: